Humana Inc. (HUM) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Humana Inc. (HUM) Healthcare & Pipeline Overview

Humana Inc. is a leading health and well-being company providing medical and supplemental benefit plans across the United States. Operating through multiple segments, Humana serves a large membership base with diverse healthcare solutions, positioning itself in a competitive healthcare landscape with a focus on integrated services and government partnerships.

What Is the Investment Thesis for HUM?

Humana Inc. presents a mixed investment case. The company's established presence in the Medicare Advantage market and its integrated healthcare service offerings provide a stable revenue base. The company's P/E ratio is 37.62, and the dividend yield is 1.29%. Growth catalysts include expansion of its Medicare and Medicaid services, and further development of its Healthcare Services segment. Potential risks include regulatory changes in the healthcare industry and increasing competition. With a market capitalization of $48.9B, Humana's financial performance and strategic initiatives warrant close monitoring.

Based on FMP financials and quantitative analysis

HUM Key Highlights

Humana has approximately 17 million members in medical benefit plans as of December 31, 2021, demonstrating a significant market presence.

• The company's gross margin is 14.0%, indicating its ability to manage the costs associated with its healthcare services.
• Humana's profit margin is 0.8%, reflecting the competitive pressures and operational expenses within the healthcare industry.
• The company's beta is 0.45, suggesting lower volatility compared to the overall market.
• Humana offers medical and supplemental benefit plans, including Medicare Advantage, Medicaid, and commercial insurance, diversifying its revenue streams.

Who Are HUM's Competitors?

HUM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HUM's Key Strengths?

Large membership base with approximately 17 million members in medical benefit plans.

• Diversified business segments, including Retail, Group and Specialty, and Healthcare Services.
• Strong presence in the Medicare Advantage market.
• Integrated care delivery model that combines health insurance with healthcare services.

What Are HUM's Weaknesses?

Relatively low profit margin of 0.8%.

• Exposure to regulatory changes and healthcare policy risks.
• Dependence on government contracts for a significant portion of revenue.
• Competitive pressures from other large health insurers.

What Could Drive HUM Stock Higher?

Expansion of Medicare Advantage plans into new geographic markets.

• Development and rollout of new digital health tools and telehealth services.
• Potential acquisitions or partnerships to expand service offerings.
• Growth in the Healthcare Services segment, including home health and pharmacy solutions.
• Government policy changes impacting Medicare and Medicaid reimbursement rates.

What Are the Key Risks for HUM?

Rich valuation — a P/E of 37.62 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.

• Regulatory changes in the healthcare industry, such as changes to the Affordable Care Act.
• Increasing competition from other health insurers and healthcare providers.
• Rising healthcare costs and medical loss ratios.
• Economic downturns that could reduce enrollment in commercial health plans.
• Cybersecurity threats and data breaches that could compromise member information.

What Are the Growth Opportunities for HUM?

• Growth opportunity 1: Expansion of Medicare Advantage offerings represents a significant growth opportunity for Humana. The Medicare Advantage market is projected to continue growing as more seniors opt for managed care plans. Humana can leverage its established brand and provider networks to increase its market share in key geographic regions. The increasing demand for specialized care within Medicare Advantage, such as chronic disease management programs, also presents opportunities for Humana to differentiate its offerings.
• Growth opportunity 2: Growth in Medicaid contracts represents a significant opportunity for Humana. The company has contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. Humana can expand its Medicaid business by bidding on new contracts and improving its service delivery. The increasing number of individuals eligible for Medicaid due to economic factors and policy changes drives this growth.
• Growth opportunity 3: Development of Healthcare Services segment, including pharmacy solutions, provider services, and home solutions, offers substantial growth potential. The market for home healthcare services is expanding due to the aging population and the desire for more convenient and cost-effective care options. Humana can leverage its existing infrastructure and partnerships to expand its home health offerings and capture a larger share of this market. This segment allows Humana to diversify its revenue streams and enhance its integrated care model.
• Growth opportunity 4: Leveraging technology to enhance member engagement and improve health outcomes is a key growth driver. Investing in telehealth platforms, digital health tools, and data analytics can enable Humana to provide more personalized and proactive care. The increasing adoption of digital health solutions by consumers and providers creates opportunities for Humana to improve member satisfaction, reduce costs, and drive better health outcomes. This includes remote monitoring, virtual consultations, and AI-powered care management.
• Growth opportunity 5: Strategic partnerships and acquisitions can accelerate Humana's growth in key markets and service areas. Collaborating with healthcare providers, technology companies, and other organizations can expand Humana's capabilities and reach. Targeted acquisitions can add new services, technologies, or geographic presence. For example, acquiring a home healthcare company or a telehealth platform can enhance Humana's integrated care offerings and expand its market reach.

What Are HUM's Competitive Advantages?

• Established brand reputation and market presence in the health insurance industry.
• Extensive provider network and relationships with healthcare providers.
• Expertise in managing government-sponsored healthcare programs, such as Medicare and Medicaid.
• Integrated care delivery model that combines health insurance with healthcare services.
• Scale and efficiency in administering health plans and processing claims.

What Does HUM Do?

Founded in 1961 and headquartered in Louisville, Kentucky, Humana Inc. has evolved into a major player in the U.S. health and well-being sector. Originally a nursing home company, Humana transitioned into health insurance in the 1980s. Today, the company operates through three primary segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment offers a variety of medical and supplemental benefit plans to individuals, including Medicare Advantage plans, prescription drug plans, and other health and wellness solutions. The Group and Specialty segment provides commercial fully insured medical and specialty health insurance benefits, such as dental, vision, and other supplemental health benefits, to employer groups. Humana also administers military services like the TRICARE T2017 East Region contract. The Healthcare Services segment delivers pharmacy solutions, provider services, and home solutions, including home health services, to both its health plan members and third parties. As of December 31, 2021, Humana served approximately 17 million members in medical benefit plans and approximately 5 million members in specialty products. Humana's strategic focus includes expanding its integrated care offerings and leveraging technology to improve member experiences and health outcomes.

What Products and Services Does HUM Offer?

• Offers medical benefit plans to individuals, including Medicare Advantage plans.
• Provides supplemental benefit plans, such as dental and vision insurance.
• Administers the Limited Income Newly Eligible Transition prescription drug plan program for the Centers for Medicare and Medicaid Services.
• Contracts with states to provide Medicaid, dual eligible, and long-term support services benefits.
• Offers commercial fully insured medical and specialty health insurance benefits to employer groups.
• Provides administrative services only products to individuals and employer groups.
• Offers military services, such as the TRICARE T2017 East Region contract.
• Provides pharmacy solutions, provider services, and home solutions services.

How Does HUM Make Money?

• Generates revenue from premiums paid by members for medical and supplemental benefit plans.
• Earns fees from administering government-sponsored healthcare programs, such as Medicare and Medicaid.
• Receives payments for providing healthcare services, including pharmacy, provider, and home health services.
• Derives income from administrative services provided to employer groups and other organizations.

What Industry Does HUM Operate In?

Humana operates in the dynamic and highly regulated U.S. healthcare industry. The industry is characterized by increasing demand for healthcare services, driven by an aging population and rising prevalence of chronic diseases. The competitive landscape includes major players like UnitedHealth Group and CVS Health, as well as regional health insurers. Market trends include a shift towards value-based care, increased adoption of telehealth, and growing focus on preventive care and wellness programs. Humana's integrated care delivery model and focus on Medicare Advantage position it to capitalize on these trends.

Who Are HUM's Key Customers?

• Individuals seeking medical and supplemental health insurance coverage.
• Seniors eligible for Medicare Advantage plans.
• Low-income individuals and families eligible for Medicaid benefits.
• Employer groups offering health insurance benefits to their employees.
• Government agencies contracting for healthcare administration services.

Company Profile

Humana Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Louisville, US. The company is led by CEO James A. Rechtin. HUM has traded publicly since 1981.

Humana Inc. Financial Trajectory

Humana Inc. (HUM) reported $40.87B in revenue for Q2 FY2026, reflecting 3.1% growth compared to the prior quarter. The company recorded net income of $693.0M, with diluted EPS of $5.73. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, HUM averaged $2.64 in diluted EPS.

How Humana Inc. Is Valued

Humana Inc. carries a market capitalization of $48.9B, placing it in the large-cap category. Analyst price targets span from $300.00 to $513.00, with a consensus of $418.53. At the current price of $407.26, that implies approximately 3% upside potential. Relative to its peer group, HUM's quantitative score of 53/100 is below the peer average of 78/100.

Return on equity for Humana Inc. stands at 6.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.0%, showing how much profit it generates from its asset base. HUM trades at a trailing price-to-earnings ratio of 37.62, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 2.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.26 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.4%, the inverse of the P/E and a quick read on earnings relative to price.

Humana Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.55 places it in the safe zone, indicating low near-term bankruptcy risk.

Humana Inc. has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 7.9% above estimates on average.

Over the past six months, Humana Inc. insiders filed 17 SEC Form 4 transactions — 1 sales and 16 purchases. On net that is roughly 116K shares acquired (about $70K) — insiders putting money in tends to read as conviction.

HUM Financials

Next earnings report: Nov 6, 2026

HUM Latest News

HUM Analyst Consensus

HUM MoonshotScore

Latest Humana Inc. Analysis

HUM Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources